Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
04/2007
04/12/2007CA2624524A1 Carbamate compounds which inhibit leukocyte adhesion mediated by vla-4
04/12/2007CA2624450A1 Pyrimidinyl amide compounds which inhibit leukocyte adhesion mediated by vla-4
04/12/2007CA2624141A1 Quinazoline derivative and pharmaceutical
04/12/2007CA2623813A1 Nitrogen-containing heterocyclic compound and pharmaceutical application thereof
04/12/2007CA2623348A1 Biaryl substituted heterocycle inhibitors of lta4h for treating inflammation
04/12/2007CA2623154A1 Novel fused pyrrole derivative
04/11/2007EP1772151A2 Method and compositions for the synthesis of bch-189 and related compounds
04/11/2007EP1771453A1 Hepatitis c inhibitor dipeptide analogs
04/11/2007EP1771442A1 Viral polymerase inhibitors
04/11/2007EP1771438A1 1-3 substituted cycloamino derivatives and their use as histamine-3 receptor antagonists
04/11/2007EP1771435A2 Modulators of central nervous system neurotransmitters
04/11/2007EP1771422A1 Quinazolinone derivatives as parp inhibitors
04/11/2007EP1771417A1 Substituted 3-phenylpiperidine derivatives
04/11/2007EP1567496B1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
04/11/2007EP1480972B1 Compounds possessing affinity at 5ht1-type receptors and use thereof in therapy of cns disorders
04/11/2007EP1313725B1 Tricyclic antitumor compounds being farnesyl protein transferase inhibitors
04/11/2007EP1307237B1 Complexes containing perfluoroalkyl with polar radicals, method for the production and use thereof
04/11/2007EP1147093B1 Substituted bicyclic derivatives useful as anticancer agents
04/11/2007EP1084107B1 Aza-heterocyclic compounds used to treat neurological disorders and hair loss
04/11/2007EP0950656B1 Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same
04/11/2007CN1946714A Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
04/11/2007CN1946713A Chemokine receptor antagonists
04/11/2007CN1946712A Pyrrolidine derivative
04/11/2007CN1946701A Tri-substituted ureas as cytokine inhibitors
04/11/2007CN1946700A Tri-substituted ureas as cytokine inhibitors
04/11/2007CN1946699A Pyridazinone ureas as antagonists of alpha4 integrins
04/11/2007CN1946696A Tetrahydropyranyl cyclopentyl 1-substituted and 1,1-disubstituted tetrahydroisoquinoline modulators of chemokine receptor activity
04/11/2007CN1946397A Ion channel modulators
04/11/2007CN1944428A Chroman compound and its preparing method and use in producing medicine
04/11/2007CN1944427A Novel macro-molecular compound, its preparing method and use
04/11/2007CN1944406A Indole heterocyclic compounds and intermediate, and synthetic method
04/11/2007CN1309704C Anthranyl amides and their use as medicaments
04/10/2007US7202350 (1S)-1,5-anhydro-1-[3-(1-benzothiene-2-ylmethyl)phenyl-D-glucitol and derivatives, are Na+-glucose cotransporter inhibitors and are used to treat diabetes and related diseases such as insulin-resistance and obesity
04/10/2007US7202279 Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
04/10/2007US7202266 PPAR active compounds
04/10/2007US7202263 [2-(Benzodioxo-5-ylalkylamino)ethoxy]-imidazol-1-yl-benzene derivatives, e.g., N-[2-(4-(imidazol-1-yl)phenoxy)ethyl]-N-[(1,3-benzodioxol-5-yl)methyl]amine; treating congestive heart failure
04/10/2007US7202254 N-(p-(substituted 1,2,3-triazol-1-yl)phenyl) derivatives of cycloazaalkanes; particularly useful for treating methicillin-resistant Staphylococcus aureas infections
04/10/2007US7202250 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders
04/10/2007US7202248 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
04/10/2007US7202244 Chk-1 inhibitors
04/10/2007US7202232 Acrylonitrile derivatives for inflammation and immune-related uses
04/10/2007CA2407100C 1-aroyl-piperidinyl benzamidines
04/10/2007CA2212895C Benzylpiperidines and piperazines as muscarinic antagonists
04/10/2007CA2204200C Phenyl alkyl ketone substituted by cyclic amine and a process for the preparation thereof
04/10/2007CA2127084C 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-ht1a-antagonistic activity
04/05/2007WO2007038772A1 Novel drugs for dementia
04/05/2007WO2007037743A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia
04/05/2007WO2007037513A1 Aryl-substituted nitrogen-containing heterocyclic compound
04/05/2007WO2007036715A2 Compounds which have activity at m1 receptor and their uses in medicine
04/05/2007WO2007036711A1 BENZIMIDAZOLONES WHICH HAVE ACTIVITY AT Ml RECEPTOR
04/05/2007WO2007036131A1 Carzole sulphamide derivatives and their preparation method
04/05/2007WO2007016012A3 CYCLOALKYL AMINO-HYDANTOIN COMPOUNDS AND USE THEREOF FOR β-SECRETASE MODULATION
04/05/2007WO2006076452A3 An exo-selective synthesis of himbacine analogs
04/05/2007WO2006058338A3 4 - piperidinecarboxamide derivatives as modulators of vanilloid vr1 receptor
04/05/2007US20070078261 Process for selectively extracting procyanidins
04/05/2007US20070078173 Alpha- and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
04/05/2007US20070078168 Pyridine carboxylic acid derivatives as glucokinase modulators
04/05/2007US20070078164 Hypotensive agents; cardiovascular disorders; anxiolytic agents; cognition activators; diabetic neuropathy; congestive heart failure; cardiomyopathy; kidney disease; Alzheimer's disease; vision defects
04/05/2007US20070078160 3-[3-(1-Ethyl-4,4,6-trimethyl-2-oxo- 1,2,3,4-tetrahydro-quinolin-7-yl)-4- (2,2,2-trifluoro-ethoxy)-phenyl]- acrylic acid;Retinoid X Receptor (RXR) agonists useful for treating the onset of cancer and metabolic disorders such as diabetes, dyslipidemia, and hypercholesterolemia
04/05/2007US20070078152 Piperidine derivatives
04/05/2007US20070078151 Crystalline and amorphous pyrimidine compounds and processes for preparing pyrimidine compounds
04/05/2007US20070078139 Phosphodiesterase 4 inhibitors
04/05/2007US20070078134 Treating sleep disorders insomnia; 1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(4-chloro-phenyl)-urea; restless leg syndrome, cardiovascular disorders, reducing blood clot
04/05/2007US20070078130 Dual alanyl aminopeptidase and dipeptidyl peptidase iv inhibitors for functionally influencing different cells and for treating immunological inflammatory, neuronal and other diseases
04/05/2007US20070078080 N4-Acylcytosine Nucleosides for Treatment of Viral Infections
04/05/2007US20070077318 Process for producing cocoa polyphenol concentrate
04/05/2007CA2624491A1 Novel azetidine compounds useful in the treatment of functional gastrointestinal disorders, ibs and functional dyspepsia
04/05/2007CA2624162A1 Aryl-substituted nitrogen-containing heterocyclic compound
04/04/2007EP1770091A1 CGRP-antagonists, process for their preparation as well as their use as medicaments
04/04/2007EP1768957A2 Indole-2-carboxylic acid hydrazides as glycogen phosphorylase inhibitors
04/04/2007EP1536797B1 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related comounds as neurokinin-1 (nk-1) antagonsists for the treatment of emesis, depression, anxiety and cough
04/04/2007EP1429607B1 Delta 1-pyrrolines used as pesticides
04/04/2007EP1377556B1 Pyrazole derivatives for treating hiv
04/04/2007EP1362033B1 Pyridine matrix metalloproteinase inhibitors
04/04/2007EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections
04/04/2007CN1942551A New organic luminescent element
04/04/2007CN1942466A Caspase inhibitors and uses thereof
04/04/2007CN1942450A Process for the preparation of substituted triazole compounds
04/04/2007CN1942445A Novel quinoline-carbaxamides as JACK3 kinase modulators
04/04/2007CN1942437A Substituted azetidine compounds as cyclooxygenase-1-cyclooxygenase-2 inhibitors, and their preparation and use as medicaments
04/04/2007CN1939307A 2,4,6-triamino-1,3,5-triazine derivative
04/04/2007CN1308324C Quinazoline derivatives as alpha-1 adrenergic antagonists
04/04/2007CN1308320C Substituted naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
04/04/2007CN1308310C Nitrogenous aromatic ring compounds
04/03/2007US7199244 Cyclic amine derivatives and methods of use
04/03/2007US7199243 Antilipemic agents; anticholesterol agents; atherosclerosis; cardiovascular disorders; obesity; antidiabetic agents
04/03/2007US7199147 Rho kinase inhibitors
04/03/2007US7199145 Derivatives of hydantoins, thiohydantoins, pyrimidinediones and thioxopyrimidinones, their preparation processes and their use as medicaments
04/03/2007US7199140 (bis(Phenoxy or phenylsulfonamido)phenylethyl)pyridyl carboxylic acids, esters or amides; antidiabetic agents; obesity; glucokinase agonists
04/03/2007US7199137 Treatment of neurotraumatic diseases, cancer, chronic neurodegeneration, pain, migraine and cardiac hypertrophy
04/03/2007US7199126 P38 MAP kinase; enzyme inhibitors; antiinflammatory agents; cardiovascular disorders
04/03/2007US7199123 Pyrazine compounds as transforming growth factor (TGF) compounds
04/03/2007US7199106 Lincomycin derivatives possessing antimicrobial activity
04/03/2007US7198958 Method for increasing hydrophilicity of fluorescent label compounds
04/03/2007CA2288140C Farnesyltransferase inhibiting quinazolinones
04/03/2007CA2236269C Selective .beta.3 adrenergic agonists
04/03/2007CA2149044C Use of dimethylbenzofurans and dimethylbenzopyrans as 5-ht3 antagonists
03/2007
03/29/2007WO2007035841A1 Analogs of dehydrophenylahistins and their therapeutic use
03/29/2007WO2007034251A1 Amino-alkyl-amide derivatives as ccr3 receptor ligands
03/29/2007WO2007002635A3 C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions